Adaptin Bio APTN Cash Flow Statement (2022-2026)

OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT
Reported Financials

Adaptin Bio Quarterly Cash Flow Statement

Periods 13 quarters
Latest Jun 2026

Adaptin Bio reported cash from operations of -$0.45M and free cash flow of -$0.45M for the quarter ended Jun 2026, up 56.0% year over year. This cash flow statement covers 13 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2022 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -0.04M-0.03M-0.34M-0.82M-1.11M-0.86M-0.60M-1.52M-1.68M-1.37M-1.15M-1.21M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges 0.03M0.02M0.08M0.11M0.05M
Share-based CompensationStock Comp. 0.32M-0.08M0.35M0.19M
Other non-cash itemsOther Non-Cash 133.000.00M0.01M0.20M-0.32M1.43M0.02M
Change in Working Capital
Change in Account PayablesChange Payables 0.28M-0.07M0.44M0.43M-0.69M0.34M0.67M0.17M-0.14M0.26M
Change in Accured ExpensesChange Accured Exp. -0.03M-0.07M0.64M0.08M0.20M-0.27M-0.26M820.000.07M0.26M-0.04M
Change in Other Operating AssetsOther Assets Change 0.47M-0.17M0.09M-0.24M-0.09M-0.09M
Change in Other Operating LiabilitiesOther Liabilities Change 0.00M0.00M0.00M0.00M0.00M-0.04M
Other Working Capital ChangesOther WC Changes 0.00M0.00M0.00M0.00M0.00M-0.04M-0.47M0.17M-0.09M0.24M0.09M0.09M
Cash from OperationsCash from Ops. -0.06M-0.09M-0.20M-0.47M0.11M-2.28M-1.02M-0.77M-0.70M-0.60M-0.45M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 0.06M0.09M0.22M0.03M
Long-Term Debt RepaymentsLT Debt Repayment 0.28M
Non-Current Debt 0.06M0.09M0.22M0.03M-0.28M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.06M0.09M0.22M0.03M-0.28M
Change in Capital Stock
Common Stock IssuedStock Issued 6.16M1.00M0.65M0.93M
Net Shares Issued and RepurchasedNet Shares Issued 6.16M1.00M0.65M0.93M
Net Equity Issued and RepurchasedNet Equity Issued 6.16M1.00M0.65M0.93M
Other financing activitiesOther financing -0.19M-1.27M-0.42M-0.21M-0.11M
Cash from Financing ActivitiesCash from Financing 0.06M0.09M0.22M0.56M-0.19M4.62M0.58M0.44M0.82M
Additional items
Change in Cash 305.000.02M0.09M-0.08M2.34M-1.02M-0.77M-0.12M-0.16M0.37M
Ending Cash Balance 500.00380.000.00M0.01M0.02M0.12M0.03M2.37M1.35M0.58M0.46M0.30M0.67M
Free Cash FlowFCF -0.06M-0.09M-0.20M-0.47M0.11M-2.28M-1.02M-0.77M-0.70M-0.60M-0.45M
Net Cash FlowNCF 305.000.02M0.09M-0.08M2.34M-1.02M-0.77M-0.12M-0.16M0.37M
Interest Paid 0.01M0.00M0.00M

Adaptin Bio Cash Flow Statement API

Pull Adaptin Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=APTN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY